Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Min's Quyu Xiaozhong Formula is a Traditional Chinese Medicine (TCM) herbal preparation originating from the Min's School of Orthopedics (Min Shi Shang Ke), a recognized lineage of Chinese traumatology based in the Shanghai region. The formula is specifically formulated to treat blood stasis and localized edema (swelling) associated with traumatic injuries and orthopedic surgeries. Its therapeutic rationale is based on the TCM principles of promoting blood circulation, resolving stasis, and clearing heat to reduce swelling. Clinically, it is primarily employed as a topical application or wash to manage postoperative limb swelling following fracture internal fixation, where it helps to reduce inflammatory markers and accelerate the recovery of limb function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Min's Quyu Xiaozhong Formula.